The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pathologic response to predict survival in patients who underwent surgery after neoadjuvant chemotherapy with bevacizumab for clinical stage II/IIIA non-squamous non-small cell lung cancer.
 
Yasuhiro Tsutani
No Relationships to Disclose
 
Yuichiro Kai
No Relationships to Disclose
 
Masaoki Ito
No Relationships to Disclose
 
Takeshi Mimura
No Relationships to Disclose
 
Yoshihiro Miyata
No Relationships to Disclose
 
Kenji Suzuki
Speakers' Bureau - Chugai Pharma; Covidien; Ethicon; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Covidien; Shionogi (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Chugai Pharma; Covidien; Ethicon; Taiho Pharmaceutical
 
Kazuya Takamochi
No Relationships to Disclose
 
Fumihiro Tanaka
No Relationships to Disclose
 
Haruhiko Nakayama
No Relationships to Disclose
 
Yoshinori Yamashita
No Relationships to Disclose
 
Makoto Oda
No Relationships to Disclose
 
Masahiro Tsuboi
No Relationships to Disclose
 
Morihito Okada
Speakers' Bureau - Taiho Pharmaceutical
Research Funding - Nippon Kayaku (Inst); Taiho Pharmaceutical (Inst)